Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia.

Blatt SP, Yultyev A, Huang M, Friedstrom S, Steinbrunner J.

Am J Infect Control. 2017 Dec 1;45(12):1396-1398. doi: 10.1016/j.ajic.2017.07.019. Epub 2017 Aug 31.

PMID:
28865937
2.

Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research.

Gardner LI, Harrison SH, Hendrix CW, Blatt SP, Wagner KF, Chung RC, Harris RW, Cohn DL, Burke DS, Mayers DL.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):345-53.

PMID:
9525436
3.

Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin.

Clerici M, Sarin A, Berzofsky JA, Landay AL, Kessler HA, Hashemi F, Hendrix CW, Blatt SP, Rusnak J, Dolan MJ, Coffman RL, Henkart PA, Shearer GM.

AIDS. 1996 Jun;10(6):603-11.

PMID:
8780814
4.

Cytomegalovirus polyradiculopathy in HIV-infected patients.

Meier PA, Stephan KT, Blatt SP.

J Gen Intern Med. 1996 Jan;11(1):47-9.

PMID:
8691287
5.

The significance of hematuria in patients infected with the human immunodeficiency virus.

Cespedes RD, Peretsman SJ, Blatt SP.

J Urol. 1995 Oct;154(4):1455-6.

PMID:
7658557
6.

In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus.

Dolan MJ, Clerici M, Blatt SP, Hendrix CW, Melcher GP, Boswell RN, Freeman TM, Ward W, Hensley R, Shearer GM.

J Infect Dis. 1995 Jul;172(1):79-87.

PMID:
7797948
7.

Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression.

Warren RQ, Wong MT, Melcher GP, Blatt SP, Zapiola I, Bouzas MB, Muchinik G, Anderson SA, Kennedy RC.

Clin Diagn Lab Immunol. 1995 Jul;2(4):400-3.

8.
9.

Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons.

Blatt SP, McCarthy WF, Bucko-Krasnicka B, Melcher GP, Boswell RN, Dolan J, Freeman TM, Rusnak JM, Hensley RE, Ward WW, et al.

J Infect Dis. 1995 Apr;171(4):837-44.

PMID:
7535828
10.

Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.

Warren RQ, Wong MT, Melcher GP, Blatt SP, Cahn P, Perez H, Zapiola I, Bouzas MB, Muchinik G, Anderson SA, et al.

J Clin Microbiol. 1995 Feb;33(2):481-3.

11.

Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis.

Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, Wolf SF, Shearer GM, Henkart PA.

Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11811-5.

12.

Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors.

Sarin A, Clerici M, Blatt SP, Hendrix CW, Shearer GM, Henkart PA.

J Immunol. 1994 Jul 15;153(2):862-72.

PMID:
8021517
14.

A case of Pott's disease in a 20-year-old military dependent.

Grinkemeyer MD, LaBarre RC, Yaszemski MJ, Klucznik RP, Blatt SP, Drehner DM.

Mil Med. 1994 Mar;159(3):257-60.

PMID:
8041480
15.

Legionnaires' disease in human immunodeficiency virus-infected patients: eight cases and review.

Blatt SP, Dolan MJ, Hendrix CW, Melcher GP.

Clin Infect Dis. 1994 Feb;18(2):227-32. Review.

PMID:
8161631
16.

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM.

J Clin Invest. 1994 Feb;93(2):768-75.

17.

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.

Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM.

Science. 1993 Dec 10;262(5140):1721-4.

PMID:
7903123
18.

Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects.

Wong MT, Warren RQ, Anderson SA, Dolan MJ, Hendrix CW, Blatt SP, Melcher GP, Boswell RN, Kennedy RC.

J Infect Dis. 1993 Dec;168(6):1523-7.

PMID:
7504036
19.

Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.

Blatt SP, Hendrix CW, Butzin CA, Freeman TM, Ward WW, Hensley RE, Melcher GP, Donovan DJ, Boswell RN.

Ann Intern Med. 1993 Aug 1;119(3):177-84.

PMID:
8100691
20.

Coccidioidomycosis: a persistent threat to deployed populations.

Rush WL, Dooley DP, Blatt SP, Drehner DM.

Aviat Space Environ Med. 1993 Jul;64(7):653-7.

PMID:
8357322
21.

Nosocomial Legionnaires' disease: aspiration as a primary mode of disease acquisition.

Blatt SP, Parkinson MD, Pace E, Hoffman P, Dolan D, Lauderdale P, Zajac RA, Melcher GP.

Am J Med. 1993 Jul;95(1):16-22.

PMID:
8328493
22.

Racial differences in serum beta 2-microglobulin in persons with human immunodeficiency virus infection.

Lucey DR, McCarthy WF, Blatt SP, Melcher GP, Hendrix CW.

J Infect Dis. 1993 May;167(5):1259-60. No abstract available.

PMID:
8486969
23.

Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons.

Blatt SP, Lucey CR, Butzin CA, Hendrix CW, Lucey DR.

JAMA. 1993 Feb 3;269(5):622-6.

PMID:
8093628
24.

Rhinocerebral zygomycosis in a patient with AIDS.

Blatt SP, Lucey DR, DeHoff D, Zellmer RB.

J Infect Dis. 1991 Jul;164(1):215-6. No abstract available.

PMID:
2056212
25.

Treatment of Listeria bacteremia with vancomycin.

Blatt SP, Zajac RA.

Rev Infect Dis. 1991 Jan-Feb;13(1):181-2. No abstract available.

PMID:
2017622

Supplemental Content

Loading ...
Support Center